Machine learning used to predict clinical response to anti-cancer drugs
Cancer treatment is a step closer to becoming personalised with Mitra, a biotechnology company in Boston, releasing a study on predicting different patients’ clinical response to anti-cancer drugs using a machine learning algorithm.